
Sign up to save your podcasts
Or


Ketamine is perhaps best known as a party drug, and it has long been used in hospitals as an anesthetic. In recent years, it has also been touted as a promising, experimental psychiatric treatment. But when Friends actor Matthew Perry overdosed on ketamine last year, it exposed a network of unregulated clinics and unscrupulous doctors distributing the drug for off-label uses. In this hour, we’ll talk with experts about what we know — so far — about ketamine’s efficacy and safety.
Guests:
Smita Das, clinical associate professor of psychiatry and behavioral sciences, Stanford Medicine; vice president of complex care and psychiatry, Lyra Health
Gerard Sanacora, professor of psychiatry and director, Yale Depression Research Program at the Yale School of Medicine
Learn more about your ad choices. Visit megaphone.fm/adchoices
By KQED4.3
695695 ratings
Ketamine is perhaps best known as a party drug, and it has long been used in hospitals as an anesthetic. In recent years, it has also been touted as a promising, experimental psychiatric treatment. But when Friends actor Matthew Perry overdosed on ketamine last year, it exposed a network of unregulated clinics and unscrupulous doctors distributing the drug for off-label uses. In this hour, we’ll talk with experts about what we know — so far — about ketamine’s efficacy and safety.
Guests:
Smita Das, clinical associate professor of psychiatry and behavioral sciences, Stanford Medicine; vice president of complex care and psychiatry, Lyra Health
Gerard Sanacora, professor of psychiatry and director, Yale Depression Research Program at the Yale School of Medicine
Learn more about your ad choices. Visit megaphone.fm/adchoices

38,430 Listeners

6,881 Listeners

9,238 Listeners

4,022 Listeners

393 Listeners

114 Listeners

247 Listeners

6,467 Listeners

1,065 Listeners

4,696 Listeners

85 Listeners

2,380 Listeners

187 Listeners

434 Listeners

131 Listeners

395 Listeners

16,512 Listeners

31 Listeners

16,525 Listeners

11,013 Listeners

1,600 Listeners